SCHEMBL19984680

SCHEMBL19984680

C=C/C(=C\C=C/C)Nc1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MAPT P10636 4/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ EPHX1 P07099 1/20 0.40
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20630255 0.87 GAA (0.46) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL26405330 0.80 KMT2A (0.54) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL27401064 0.78 KMT2A (0.47) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL20412292 0.76 GAA (0.51) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL15292671 0.74 TGM2 (0.47) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL20008068 0.74 TGM2 (0.47) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL19954739 0.74 KDM4E (0.56) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL24004141 0.73 GAA (0.51) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL24766141 0.72 KMT2A (0.55) KMT2AMEN1KDM4EGAARAB9A
SCHEMBL21431577 0.72 KMT2A (0.51) KMT2AMEN1KDM4EGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778832-A1 LUBRICATING OIL COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2021-02-17 — — EP disclosed
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants LANXESS SOLUTIONS US INC. (US) 2020-10-20 — — US disclosed
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS CORPORATION 2018-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants GPX4, CAT, SOD1 KMT2A 1818/4885MEN1 4755/4885KDM4E 1996/4885
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS GPX4, CAT, SOD1 KMT2A 1818/4885MEN1 4755/4885KDM4E 1996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback